Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
Laser based charging system aims to keep drones airborne indefinitely by delivering kilowatt class power over long distances ...
News-Medical.Net on MSN
Purdue-developed LENN system enhances stability and targeting of mRNA cancer therapies
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
AbCellera today announced that the first patients have been dosed in the Phase 2 portion of its ongoing Phase 1/2 clinical ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
Genomics, Inc. , a leader in single cell and spatial biology, today announced a collaboration with the Cancer Research Institute (CRI) to advance the frontiers of immuno-oncology through ...
Detailed price information for Infosys Ltd ADR (INFY-N) from The Globe and Mail including charting and trades.
A critical misconfiguration in AWS's CodeBuild service allowed complete takeover of the cloud provider's own GitHub ...
Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutationsAdolore's Kv7 voltage-gated po ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback